Nordic Guidelines 2010 for diagnosis and treatment of gastroenteropancreatic neuroendocrine tumours.
about
Gastroenteropancreatic high-grade neuroendocrine carcinomaThe biological hallmarks of ileal carcinoidsTopotecan monotherapy in heavily pretreated patients with progressive advanced stage neuroendocrine carcinomasClinical and pathological features of non-functional neuroendocrine tumors of pancreas: a report from iranGastric neuroendocrine tumours.Searching for primaries in patients with neuroendocrine tumors (NET) of unknown primary and clinically suspected NET: Evaluation of Ga-68 DOTATOC PET/CT and In-111 DTPA octreotide SPECT/CTGastroenteropancreatic Neuroendocrine Tumors with Liver Metastases in Korea: A Clinicopathological Analysis of 72 Cases in a Single InstituteGoblet cell carcinoid in a patient with neurofibromatosis type 1: a rare combination.Improvement in Stress, General Self-Efficacy, and Health Related Quality of Life following Patient Education for Patients with Neuroendocrine Tumors: A Pilot Study.Therapy of metastatic pancreatic neuroendocrine tumors (pNETs): recent insights and advancesProspective of ⁶⁸Ga-radiopharmaceutical development.Alternative polyadenylation of tumor suppressor genes in small intestinal neuroendocrine tumors.The archaic distinction between functioning and nonfunctioning neuroendocrine neoplasms is no longer clinically relevant.Safety review: dose optimization of somatostatin analogs in patients with acromegaly and neuroendocrine tumors.Chromogranin A: a sensitive biomarker for the detection and post-treatment monitoring of gastroenteropancreatic neuroendocrine tumors.A case of insulin and ACTH co-secretion by a neuroendocrine tumour.Neuroendocrine Carcinoma of Gall Bladder: A Series of 19 Cases with Review of Literature.Potent antitumor activity of the novel HSP90 inhibitors AUY922 and HSP990 in neuroendocrine carcinoid cells.A descriptive cross-sectional study of pain in patients with neuroendocrine tumors.First-line treatment of patients with disseminated poorly differentiated neuroendocrine carcinomas with carboplatin, etoposide, and vincristine: a single institution experience.Tissue microarray analysis as a screening tool for neuroendocrine carcinoma of the breast.Effects of Sandostatin LAR on gastrointestinal motility in patients with neuroendocrine tumors.Cost comparison of 111In-DTPA-octreotide scintigraphy and 68Ga-DOTATOC PET/CT for staging enteropancreatic neuroendocrine tumours.Surgical treatment of sporadic pancreatic neuroendocrine tumors: a state of the art review.Temozolomide as second or third line treatment of patients with neuroendocrine carcinomas.Incidence and survival of patients with small intestinal neuroendocrine tumours in a Danish NET center.Surgical approach
P2860
Q26998392-3CAA639E-4944-4F83-BE50-93EF935F9EE4Q28238359-951BECB3-6919-48FB-8D09-0BFD1938C39FQ33417320-E00B5690-AD35-41E4-BE86-79AEBA4DD4CAQ33993022-D00AB0E8-D04C-48BB-A169-EB348730F184Q34306680-27FB0D24-73C1-4BB5-ABC5-C8A580B58B6AQ34503869-0CBAC565-2999-4A79-B9E0-042CF66E1485Q36187104-B8D1F68A-9EA2-425A-A2C2-8E47E696DB32Q36486296-6F071EC4-B2E0-42FD-876E-B5B5A5272638Q36848763-51300EB2-BD4C-4608-A2BD-3E9598504A37Q37125550-6BF72054-192A-42D0-9242-53BBD3AFF8FEQ37435222-2376CF5D-B682-475B-9886-EE7587E81952Q37715730-5394AB2D-5B96-4151-9A4C-274AB11A9E0AQ37869391-0AC4F521-693F-4D3B-B230-DD5123FC2E46Q37941521-2048AC15-FCEE-4842-B3FC-A0ED56801D7CQ38014495-0192680E-31D7-4017-AFA3-905E45BD3702Q38499103-C9606156-56A4-4556-85E0-06F8CD8418B2Q38553657-F0686C0B-8AB4-4EE1-BE5A-F6071EA9A732Q39084975-0A17DF40-97F6-44DD-96FE-B47081958207Q39144954-82A0DC84-2364-45A1-9349-A17C5FF0D240Q44115095-017E8383-22D2-48B2-8F04-9B969CCB2F50Q46661732-27D35E40-52DC-4749-9712-5B5616E6E906Q50679640-9DFB883D-EDA0-4A41-9B49-CD0B04ED8409Q52892914-7EDCDED5-25DD-4D96-AADB-85F37E6D95C5Q55192213-BBA2FC42-9C99-46E0-AA95-31C15CA1B9D4Q55360978-CE7BBB2D-B1D9-4566-A445-9BC180B22298Q55395373-83675E5E-0A08-4F26-A02B-D52011FBDE9AQ57820046-D12B4D21-B54B-4575-AD97-936C5714323F
P2860
Nordic Guidelines 2010 for diagnosis and treatment of gastroenteropancreatic neuroendocrine tumours.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on August 2010
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Nordic Guidelines 2010 for dia ...... reatic neuroendocrine tumours.
@en
Nordic Guidelines 2010 for dia ...... reatic neuroendocrine tumours.
@nl
type
label
Nordic Guidelines 2010 for dia ...... reatic neuroendocrine tumours.
@en
Nordic Guidelines 2010 for dia ...... reatic neuroendocrine tumours.
@nl
prefLabel
Nordic Guidelines 2010 for dia ...... reatic neuroendocrine tumours.
@en
Nordic Guidelines 2010 for dia ...... reatic neuroendocrine tumours.
@nl
P2093
P2860
P1433
P1476
Nordic Guidelines 2010 for dia ...... creatic neuroendocrine tumours
@en
P2093
Anders Sundin
Birgitte Federspiel
Espen Thiis-Evensen
Eva Tiensuu Janson
Halfdan Sørbye
Henning Grønbaek
Kjell Oberg
Matti J Välimäki
Oystein Mathisen
Per Hellman
P2860
P304
P356
10.3109/0284186X.2010.492791
P577
2010-08-01T00:00:00Z